Top pick
1
Editor's Choice
FDA-approved tirzepatide for weight loss
- Most effective FDA-approved weight-loss medication to date, with up to about 22.5% average body-weight loss at the 15 mg dose in SURMOUNT-1
- Demonstrated head-to-head superiority over Wegovy (20.2% vs 13.7%) in the SURMOUNT-5 NEJM trial
- Convenient once-weekly injection with a flexible dosing window (can be taken up to 4 days late)
FDA-approvedBrand-nameOnce-weekly injectionDual GIP / GLP-1Insurance eligible